- Home
- ENZ vs CVM Comparison
ENZ vs CVM Comparison
Compare ENZ & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENZ
- CVM
- Stock Information
- Founded
- ENZ 1976
- CVM 1983
- Country
- ENZ United States
- CVM United States
- Employees
- ENZ N/A
- CVM N/A
- Industry
- ENZ Medical Specialities
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ENZ Health Care
- CVM Health Care
- Exchange
- ENZ Nasdaq
- CVM Nasdaq
- Market Cap
- ENZ 34.2M
- CVM 40.1M
- IPO Year
- ENZ N/A
- CVM 1987
- Fundamental
- Price
- ENZ $0.66
- CVM $0.40
- Analyst Decision
- ENZ
- CVM
- Analyst Count
- ENZ 0
- CVM 0
- Target Price
- ENZ N/A
- CVM N/A
- AVG Volume (30 Days)
- ENZ 154.0K
- CVM 2.0M
- Earning Date
- ENZ 03-12-2025
- CVM 01-13-2025
- Dividend Yield
- ENZ 61.07%
- CVM N/A
- EPS Growth
- ENZ N/A
- CVM N/A
- EPS
- ENZ N/A
- CVM N/A
- Revenue
- ENZ $30,314,000.00
- CVM N/A
- Revenue This Year
- ENZ N/A
- CVM N/A
- Revenue Next Year
- ENZ N/A
- CVM $152.91
- P/E Ratio
- ENZ N/A
- CVM N/A
- Revenue Growth
- ENZ N/A
- CVM N/A
- 52 Week Low
- ENZ $0.63
- CVM $0.36
- 52 Week High
- ENZ $1.41
- CVM $3.08
- Technical
- Relative Strength Index (RSI)
- ENZ 31.11
- CVM 38.00
- Support Level
- ENZ $0.63
- CVM $0.37
- Resistance Level
- ENZ $0.72
- CVM $0.42
- Average True Range (ATR)
- ENZ 0.04
- CVM 0.04
- MACD
- ENZ 0.01
- CVM -0.00
- Stochastic Oscillator
- ENZ 19.23
- CVM 11.83
About ENZ Enzo Biochem Inc. ($0.01 Par Value)
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.